These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38281182)

  • 1. Using synchrotron high-resolution powder X-ray diffraction for the structure determination of a new cocrystal formed by two active principle ingredients.
    Guerain M; Correia NT; Roca-Paixão L; Chevreau H; Affouard F
    Acta Crystallogr C Struct Chem; 2024 Feb; 80(Pt 2):37-42. PubMed ID: 38281182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure determination of a new cocrystal of carbamazepine and DL-tartaric acid by synchrotron powder X-ray diffraction.
    Guerain M; Derollez P; Roca-Paixão L; Dejoie C; Correia NT; Affouard F
    Acta Crystallogr C Struct Chem; 2020 Mar; 76(Pt 3):225-230. PubMed ID: 32132279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure determination of riboflavin by synchrotron high-resolution powder X-ray diffraction.
    Guerain M; Affouard F; Henaff C; Dejoie C; Danède F; Siepman J; Siepman F; Willart JF
    Acta Crystallogr C Struct Chem; 2021 Dec; 77(Pt 12):800-806. PubMed ID: 34864723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure determination of phase II of the antifungal drug griseofulvin by powder X-ray diffraction.
    Mahieu A; Willart JF; Guerain M; Derollez P; Danéde F; Descamps M
    Acta Crystallogr C Struct Chem; 2018 Mar; 74(Pt 3):321-324. PubMed ID: 29504561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between synthesis method-crystal structure-melting properties in cocrystals: the case of caffeine-citric acid.
    Guerain M; Chevreau H; Guinet Y; Paccou L; Elkaïm E; Hédoux A
    Acta Crystallogr C Struct Chem; 2024 Jun; 80(Pt 6):221-229. PubMed ID: 38712544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucopterin, the white pigment in butterfly wings: structural analysis by PDF fit, FIDEL fit, Rietveld refinement, solid-state NMR and DFT-D.
    Bravetti F; Tapmeyer L; Skorodumov K; Alig E; Habermehl S; Hühn R; Bordignon S; Gallo A; Nervi C; Chierotti MR; Schmidt MU
    IUCrJ; 2023 Jul; 10(Pt 4):448-463. PubMed ID: 37335768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of paracetamol orthorhombic Form III and determination of a novel low-temperature monoclinic Form III-m from powder diffraction data.
    Reiss CA; Mechelen JBV; Goubitz K; Peschar R
    Acta Crystallogr C Struct Chem; 2018 Mar; 74(Pt 3):392-399. PubMed ID: 29504571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first protein crystal structure determined from high-resolution X-ray powder diffraction data: a variant of T3R3 human insulin-zinc complex produced by grinding.
    Von Dreele RB; Stephens PW; Smith GD; Blessing RH
    Acta Crystallogr D Biol Crystallogr; 2000 Dec; 56(Pt 12):1549-53. PubMed ID: 11092920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Situ Investigation of a Self-Accelerated Cocrystal Formation by Grinding Pyrazinamide with Oxalic Acid.
    Kulla H; Greiser S; Benemann S; Rademann K; Emmerling F
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27428942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen bonding patterns and C-H...π interactions in the structure of the antiparkinsonian drug (R)-rasagiline mesylate determined using laboratory and synchrotron X-ray powder diffraction data.
    Dugarte-Dugarte AJ; Toro RA; van de Streek J; Henao JA; Fitch AN; Dejoie C; Delgado JM; Díaz de Delgado G
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2023 Dec; 79(Pt 6):462-472. PubMed ID: 37820013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate unrestrained DDM refinement of crystal structures from highly distorted and low-resolution powder diffraction data.
    Solovyov LA
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2016 Oct; 72(Pt 5):738-743. PubMed ID: 27698315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of Pigment Yellow 181 dimethylsulfoxide N-methyl-2-pyrrolidone (1:1:1) solvate from XRPD + DFT-D.
    van de Streek J
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2015 Feb; 71(Pt 1):89-94. PubMed ID: 25643720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Al,Mg)
    Wong C; Styles MJ; Zhu S; Qiu D; McDonald SD; Zhu Y; Gibson MA; Abbott TB; Easton MA
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2018 Aug; 74(Pt 4):370-375. PubMed ID: 30141422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in-depth structure determination of a novel metastable high-pressure CrTe
    Voss L; Gaida NA; Hansen AL; Etter M; Wolff N; Duppel V; Lotnyk A; Bensch W; Ebert H; Mankovsky S; Polesya S; Bhat S; Farla R; Hasegawa M; Sasaki T; Niwa K; Kienle L
    J Appl Crystallogr; 2024 Jun; 57(Pt 3):755-769. PubMed ID: 38846770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mg(1 + x)Ir(1 - x) (x = 0, 0.037 and 0.054), a binary intermetallic compound with a new orthorhombic structure type determined from powder and single-crystal X-ray diffraction.
    Cerný R; Renaudin G; Favre-Nicolin V; Hlukhyy V; Pöttgen R
    Acta Crystallogr B; 2004 Jun; 60(Pt 3):272-81. PubMed ID: 15148430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ab initio structure determination of monoclinic 2,2-dihydroxymethylbutanoic acid from synchrotron radiation powder diffraction data: combined use of direct methods and the Monte Carlo method.
    Tanahashi Y; Nakamura H; Yamazaki S; Kojima Y; Saito H; Ida T; Toraya H
    Acta Crystallogr B; 2001 Apr; 57(Pt 2):184-9. PubMed ID: 11262433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cynarine monohydrate from synchrotron powder X-ray diffraction data.
    Kaduk JA; Boaz NC; Markun EL; Gindhart AM; Blanton TN
    Acta Crystallogr C Struct Chem; 2022 Feb; 78(Pt 2):101-106. PubMed ID: 35119388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambiguous structure determination from powder data: four different structural models of 4,11-di-fluoro-quinacridone with similar X-ray powder patterns, fit to the PDF, SSNMR and DFT-D.
    Schlesinger C; Fitterer A; Buchsbaum C; Habermehl S; Chierotti MR; Nervi C; Schmidt MU
    IUCrJ; 2022 Jul; 9(Pt 4):406-424. PubMed ID: 35844476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example.
    Brüning J; Schmidt MU
    J Pharm Pharmacol; 2015 Jun; 67(6):773-81. PubMed ID: 25677117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenging case of the theophylline-benzamide cocrystal.
    Fischer F; Schmidt MU; Greiser S; Emmerling F
    Acta Crystallogr C Struct Chem; 2016 Mar; 72(Pt 3):217-24. PubMed ID: 26942431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.